8-K: Veru Inc. Receives Nasdaq Notification of Non-Compliance with Minimum Bid Price Rule

Veru Inc. has been notified by Nasdaq that it is not in compliance with the minimum bid price requirement, as its stock price has been below $1.00 for 30 consecutive business days.

Summary

• Veru Inc. received a notification from Nasdaq on January 25, 2024, stating that the company is not compliant with the minimum bid price requirement of $1.00 per share.
• This non-compliance is due to the company's stock price closing below $1.00 for 30 consecutive business days.
• The notification does not immediately affect the listing of Veru's common stock on the Nasdaq Capital Market.
• Veru has 180 calendar days, until July 23, 2024, to regain compliance by having its stock price close at or above $1.00 for at least 10 consecutive trading days.
• Nasdaq may extend the 10-day period at its discretion.
• If compliance is not achieved by July 23, 2024, Veru may be eligible for an additional 180-day compliance period if it meets other listing requirements and provides written notice of its intention to cure the deficiency, potentially through a reverse stock split.
• Failure to regain compliance within the extended period could result in delisting from Nasdaq.

Sentiment

Score: 3

Explanation: The document indicates a significant negative event (non-compliance with Nasdaq listing rules) and potential for delisting, which is concerning for investors. The company has a period to regain compliance, but the situation is still unfavorable.

Positives

• The notification does not immediately impact the listing of Veru's common stock on the Nasdaq Capital Market.
• Veru has a 180-day period to regain compliance, providing time to address the stock price issue.
• There is a possibility of an additional 180-day compliance period if the company meets certain requirements.

Negatives

• Veru's stock price has been below $1.00 for 30 consecutive business days, triggering the non-compliance notification.
• Failure to regain compliance within the given timeframes could result in delisting from the Nasdaq Capital Market.

Risks

• The company faces the risk of delisting from Nasdaq if it cannot increase its stock price above $1.00 within the specified timeframes.
• A reverse stock split may be necessary to regain compliance, which could negatively impact shareholder value.
• The company's ability to raise capital may be affected by the non-compliance status.

Future Outlook

The company must regain compliance with the minimum bid price requirement by July 23, 2024, or potentially face delisting. They may need to implement a reverse stock split if the stock price does not recover.

Industry Context

This type of notification is not uncommon for companies listed on the Nasdaq Capital Market, which has less stringent listing requirements than the Nasdaq Global Market. Companies in the biotech sector, like Veru, can experience stock price volatility due to clinical trial results and regulatory approvals.

Comparison to Industry Standards

• Many small-cap biotech companies face similar challenges in maintaining their stock price above the minimum bid price requirement.
• Companies like Agenus Inc. and Cassava Sciences have also faced similar delisting warnings from Nasdaq in the past.
• The 180-day compliance period is a standard procedure for Nasdaq-listed companies facing this issue.
• A reverse stock split is a common strategy used by companies to regain compliance, although it can be viewed negatively by investors.

Stakeholder Impact

• Shareholders face the risk of potential delisting and loss of investment value.
• Employees may experience uncertainty due to the company's financial challenges.
• The company's ability to raise capital may be affected, potentially impacting future operations.

Next Steps

• Veru Inc. needs to increase its stock price to at least $1.00 for a minimum of 10 consecutive trading days before July 23, 2024.
• The company may need to consider a reverse stock split if the stock price does not recover.
• Veru must meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, to qualify for an additional 180-day compliance period.

Key Dates

Keywords

Nasdaq, delisting, minimum bid price, compliance, stock price, reverse stock split, VERU